Medistim ASA

Equities

MEDI

NO0010159684

Advanced Medical Equipment & Technology

Market Closed - Oslo Bors Other stock markets 10:45:00 2024-04-29 am EDT			5-day change	1st Jan Change
180 ^NOK	+2.86%		+2.27%	-15.89%

Apr. 25	Transcript : Medistim ASA, Q1 2024 Earnings Call, Apr 25, 2024
Apr. 24	Medistim ASA Approves Dividend for the Year 2023, Payable on May 6, 2024	CI

Medistim : Presentation of Medistim’s Q1 2024 Financial Results

April 03, 2024 at 08:28 am EDT

Medistim ASA invites you to the presentation of the financial results for the first quarter 2024

The financials will be presented via a live webinar on Thursday,April 25 from 09:00-10:00 (CEST). Representatives for the company will be President and CEO Kari Eian Krogstad and CFO Thomas Jakobsen. The recording will be made available on the Medistim website shortly afterward. Register below:

Attachments

Original Link
Permalink

Disclaimer

Medistim ASA published this content on 03 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 April 2024 12:27:05 UTC.

Latest news about Medistim ASA

Transcript : Medistim ASA, Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25
Medistim ASA Approves Dividend for the Year 2023, Payable on May 6, 2024	Apr. 24	CI
Medistim ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 14	CI
Medistim ASA Proposes Dividend	Apr. 02	CI
Medistim ASA Announces Board Changes	Apr. 02	CI
Medistim ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 29	CI
Medistim Asa Proposes Dividend for the Year 2023, Payable on 6 May 2024	Feb. 29	CI
Transcript : Medistim ASA, Q4 2023 Earnings Call, Feb 29, 2024	Feb. 29
Medistim ASA Opens Direct Sales Office in Sweden	23-10-31	CI
Medistim Opens New Sales Office in Sweden	23-10-31	MT
Transcript : Medistim ASA, Q3 2023 Earnings Call, Oct 27, 2023	23-10-27
Medistim ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-26	CI
Transcript : Medistim ASA, H1 2023 Earnings Call, Aug 31, 2023	23-08-31
Medistim ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-30	CI
Medistim Signs Partnership With ROMA-Women Cardiac Surgery Trial	23-06-05	MT
Transcript : Medistim ASA, Q1 2023 Earnings Call, Apr 25, 2023	23-04-25
Medistim ASA Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24	CI
Medistim ASA Approves Dividend for the Financial Year 2022	23-04-23	CI
Medistim ASA Proposes Ordinary Dividend for 2022, Payable on May 05, 2023	23-04-03	CI
Norway's Medistim to Widen Market Coverage in China via New Direct Sales Office	23-04-03	MT
Medistim Asa Announces Expanding Market Coverage in China by Establishing A Direct Sales Office	23-04-02	CI
Norway's Medistim Expands in Canada	23-03-20	MT
Medistim ASA Suggests Dividend	23-03-01	CI
Medistim ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-01	CI
Medistim ASA Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-01	CI

Chart Medistim ASA

Duration

Period

More charts

Company Profile

Medistim ASA is a Norway-based company engaged in the provision of medical equipment and technology. It develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The Company provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistimâs activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-15 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Medistim ASA

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

180 NOK

Average target price

190 NOK

Spread / Average Target

+5.56%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
MEDISTIM ASA	-15.89%	290M
THERMO FISHER SCIENTIFIC	+8.69%	219B
DANAHER CORPORATION	+6.69%	183B
INTUITIVE SURGICAL, INC.	+10.90%	133B
BOSTON SCIENTIFIC CORPORATION	+25.41%	108B
SIEMENS HEALTHINEERS AG	+0.27%	63.06B
EDWARDS LIFESCIENCES CORPORATION	+12.72%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+3.96%	48.2B
AGILENT TECHNOLOGIES, INC.	+0.40%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+15.03%	39.35B

Other Advanced Medical Equipment & Technology